Form 4: Paychex Director Joseph Tucci Boosts Holdings
Insider Transaction Report
Paychex Director Joseph M. Tucci reported the acquisition of 725 common shares and 3,061 stock options, increasing his beneficial ownership.
Summary
- Joseph M. Tucci, a Director of Paychex Inc. (PAYX), reported transactions on October 15, 2025.
- Acquired 725 shares of Common Stock at a price of $0, identified as an award of restricted stock units (RSUs) subject to vesting under the Amended and Restated 2002 Stock Incentive Plan.
- Following this transaction, beneficial ownership of Common Stock stands at 67,364 shares.
- Acquired 3,061 Stock Options with an exercise price of $127.52 per share.
- These newly acquired options become exercisable on October 15, 2026, and expire on October 14, 2035.
- Tucci also holds several other stock options with varying exercise prices and expiration dates, totaling 57,744 derivative securities.
Sentiment
Score: 7
Explanation: The acquisition of restricted stock units and stock options by a director, as part of a compensation plan, generally indicates alignment of interests with shareholders and a long-term commitment to the company. This is a moderately positive signal.
Positives
- Director Joseph M. Tucci increased his beneficial ownership of Paychex common stock by 725 shares through an RSU award.
- The acquisition of 3,061 stock options provides a long-term incentive for the director, aligning his interests with shareholder value.
Negatives
- No negative transactions (e.g., sales) were reported in this filing.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation Plan Reference | The award of restricted stock units was made pursuant to the Amended and Restated 2002 Stock Incentive Plan, indicating the company's established equity compensation framework. | NA | Reinforces the existing governance structure for director compensation. |
Related Party Transactions
- The reported transactions involve a director of Paychex Inc. acquiring company securities, which constitutes a related party transaction.
Stakeholder Impact
- Shareholders: Increased insider ownership, even through compensation, can be viewed positively as it aligns management's interests with shareholder value.
- Employees: The existence of a stock incentive plan suggests a framework for equity compensation, potentially impacting employee retention and motivation if similar plans are available.
Next Steps
- Vesting of the 725 restricted stock units.
- Future exercisability of the 3,061 stock options starting October 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/07/2017 | Date exercisable for 10,220 stock options with an exercise price of $60.59. |
| 07/13/2018 | Date exercisable for 9,615 stock options with an exercise price of $57.20. |
| 07/12/2019 | Date exercisable for 8,641 stock options with an exercise price of $70.37. |
| 07/11/2020 | Date exercisable for 7,929 stock options with an exercise price of $85.33. |
| 07/15/2021 | Date exercisable for 5,793 stock options with an exercise price of $73.53. |
| 07/15/2022 | Date exercisable for 5,075 stock options with an exercise price of $112.67. |
| 07/15/2023 | Date exercisable for 3,027 stock options with an exercise price of $115.00. |
| 07/15/2024 | Date exercisable for 3,382 stock options with an exercise price of $120.86. |
| 07/15/2025 | Date exercisable for 3,351 stock options with an exercise price of $121.63. |
| 10/15/2025 | Date of earliest transaction; acquisition of 725 common shares (RSUs) and 3,061 stock options. |
| 10/17/2025 | Signature date of the reporting person's attorney-in-fact. |
| 07/06/2026 | Expiration date for 10,220 stock options. |
| 07/15/2026 | Date exercisable for 670 stock options with an exercise price of $140.68. |
| 10/15/2026 | Date exercisable for 3,061 newly acquired stock options with an exercise price of $127.52. |
| 07/12/2027 | Expiration date for 9,615 stock options. |
| 07/11/2028 | Expiration date for 8,641 stock options. |
| 07/10/2029 | Expiration date for 7,929 stock options. |
| 07/14/2030 | Expiration date for 5,793 stock options. |
| 07/14/2031 | Expiration date for 5,075 stock options. |
| 07/14/2032 | Expiration date for 3,027 stock options. |
| 07/14/2033 | Expiration date for 3,382 stock options. |
| 07/14/2034 | Expiration date for 3,351 stock options. |
| 07/14/2035 | Expiration date for 670 stock options. |
| 10/14/2035 | Expiration date for 3,061 newly acquired stock options. |
Recommendation
holdThe filing details a routine insider acquisition of restricted stock units and stock options as part of a director's compensation. While insider ownership alignment is positive, this specific transaction, being an award rather than an open market purchase, does not provide sufficient new information to alter an existing investment recommendation. Investors should consider broader company fundamentals and market conditions.
Keywords
Paychex, PAYX, Joseph Tucci, Insider Transaction, Form 4, Stock Options, Restricted Stock Units, Director Compensation, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.